comparemela.com

Latest Breaking News On - இன்சுலின் டெலிவரி - Page 1 : comparemela.com

Insulin Delivery Devices Market is expected to reach US$ 22,830 0 Mn with a CAGR of 8 7% from 2018-2025

Insulin Delivery Devices Market is expected to reach US$ 22,830 0 Mn with a CAGR of 8 7% from 2018-2025
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

Stem Cell Therapy for Type 1 Diabetes

Stem Cell Therapy for Type 1 Diabetes by Jayashree on  June 9, 2021 at 9:45 PM Recently developing a promising approach for treating this condition is reported in the journal Nature Communications by Scientists at the Salk Institute using stem cells to create insulin-producing cells (called beta cells) to replace non-functional pancreatic cells with proven results in mouse model. Stem cells are an extremely promising approach for developing many cell therapies, including better treatments for type 1 diabetes, says Salk Professor Juan Carlos Izpisua Belmonte, the paper s senior author. ‘New stem cell therapy can effective to treat type 1 diabetes.’ The investigators started with human pluripotent stem cells (hPSCs) having the potential to become any kind of cell found in the adult body coaxed into beta cells in a stepwise fashion that mimicked pancreatic development using various growth factors and chemicals resulted in about 10 to 40 percent of cel

Diabetes Insulin Delivery Pens Market Forecast Covering Growth Inclinations & Development Strategie

Cell Stress Mechanisms in Liver Disease Identified

Cell Stress Mechanisms in Liver Disease Identified by Colleen Fleiss on  April 1, 2021 at 7:11 AM A new prognostic factor for primary sclerosing cholangitis (PSC) from liver biopsies has been identified by researchers. This is so-called cellular ER stress. Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat, since its causes have not yet been adequately researched. PSC is a rare disease with a poor prognosis and can lead to cirrhosis of the liver or bile duct cancer. It affects 0.01% of the population but, even though it is rare, PSC is responsible for more than 10% of all liver transplants, making it the third most common indication on liver transplant waiting lists in Europe.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.